NCT03553576

Brief Summary

Neuraxial labor analgesia is performed by the administration of a local anesthetic/opioid mixture in the epidural space. The delivery method is a combination of continuous infusion, provider-administered boluses and patient-administered boluses (patient controlled epidural analgesia \[PCEA\]) via epidural catheter. The anesthetic solution administered through the lumbar epidural catheter must spread cephalad in the epidural space to reach the T10 nerve roots and spinal cord, and must spread caudad to reach the caudal nerve roots in the epidural space. Epidural infusion pumps capable of delivering PIEB of local anesthetic with PCEA have become commercially available and many studies have attempted to assess the optimal parameter settings (including volume of programmed bolus, bolus interval, rate of bolus administration) to provide superior labor analgesia. Traditionally higher concentration local anesthetic solutions have been associated with increased motor blockade leading to a higher incidence of instrumental vaginal delivery. Several local anesthetic solutions with varying drug concentrations are available for labor analgesia and are used clinically in the United States. We plan to perform a randomized, controlled, double-blind study to test the hypothesis that patients whose labor analgesia is maintained using PIEB with low-volume bolus (6.25 mL) of a higher local anesthetic concentration solution (0.1% bupivacaine with fentanyl 2.0 mcg/mL) will require less supplemental analgesia (manual provider re-doses) than patients whose PIEB is delivered with a high-volume bolus (10 mL) of lower density local anesthetic solution (0.0625% bupivacaine with fentanyl 2.0 mcg/mL). The aim of this study is to evaluate the association between bolus volume and concentration of local anesthetic during maintenance of labor analgesia with programmed intermittent epidural bolus (PIEB) analgesia. The hypothesis of this study is: patients whose labor analgesia is maintained using PIEB with low-volume bolus (6.25 mL) of higher local anesthetic concentration solution (0.1% bupivacaine with fentanyl 2.0 mcg/mL) will have a longer duration of adequate analgesia (time to first manual re-dose request) than patients whose PIEB is delivered with a high-volume bolus (10 mL) of lower concentration local anesthetic solution (0.0625% bupivacaine with fentanyl 2.0 mcg/mL).

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
146

participants targeted

Target at P75+ for phase_4 pain

Timeline
Completed

Started Jan 2020

Longer than P75 for phase_4 pain

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 30, 2018

Completed
13 days until next milestone

First Posted

Study publicly available on registry

June 12, 2018

Completed
1.6 years until next milestone

Study Start

First participant enrolled

January 21, 2020

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2023

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2023

Completed
2 years until next milestone

Results Posted

Study results publicly available

May 21, 2025

Completed
Last Updated

May 21, 2025

Status Verified

May 1, 2025

Enrollment Period

3.4 years

First QC Date

May 30, 2018

Results QC Date

May 6, 2024

Last Update Submit

May 19, 2025

Conditions

Keywords

Labor painEpiduralObstetricLabor Analgesia

Outcome Measures

Primary Outcomes (1)

  • Anesthesia Provider Administered Bolus

    Anesthesia provider (MD) administered boluses of additional anesthetic administered prior to the delivery of the baby.

    72 hours

Secondary Outcomes (14)

  • VAS at 10 Centimeters Dilation of Cervix

    24 hours

  • VAS Score After Delivery

    24 hours

  • Intrascapular Pain

    72 hours

  • Provider Administered Bolus

    72 hours

  • Number of Participants Who Required Additional Provider Redoses

    72 hours

  • +9 more secondary outcomes

Study Arms (2)

Low volume bolus

EXPERIMENTAL

6.25 mL administration at 250 ml per hour of a greater density solution (0.1% bupivacaine with fentanyl 2.0 mcg/mL)

Drug: Low volume bolus

High volume bolus

EXPERIMENTAL

10 mL administration of a lower density local anesthetic (0.0625% bupivacaine with fentanyl 2.0 mcg/mL).

Drug: High volume bolus

Interventions

Administration of a low-volume bolus (6.25 mL) of greater density solution (0.1% bupivacaine with fentanyl 2.0 mcg/mL) at 250 mL per hour given by CADD pump.

Low volume bolus

Administration of a high-volume bolus (10 mL) of lower density local anesthetic (0.0625% bupivacaine with fentanyl 2.0 mcg/mL) at 250 mL per hour given by CADD pump.

High volume bolus

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsPregnant female
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years and above
  • Nulliparous parturients
  • Present to the labor and delivery unit for an induction of labor or who are in spontaneous labor
  • Request neuraxial labor analgesia at ≤5 cm cervical dilation

You may not qualify if:

  • Patients who are not eligible to receive a combined spinal epidural (CSE) technique with 25 mcg of intrathecal fentanyl
  • Non-English speaking
  • Failed initiation of CSE analgesia (VAS pain score \>10 15 minutes after intrathecal dose)
  • Need to have the epidural catheter replaced during labor
  • Who deliver within 90 minutes of initiation of labor analgesia
  • Require re-dose within 90 minutes of initiation of labor analgesia.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Prentice Women's Hospital

Chicago, Illinois, 60611, United States

Location

Related Publications (6)

  • Wong CA, Ratliff JT, Sullivan JT, Scavone BM, Toledo P, McCarthy RJ. A randomized comparison of programmed intermittent epidural bolus with continuous epidural infusion for labor analgesia. Anesth Analg. 2006 Mar;102(3):904-9. doi: 10.1213/01.ane.0000197778.57615.1a.

    PMID: 16492849BACKGROUND
  • Lim Y, Sia AT, Ocampo C. Automated regular boluses for epidural analgesia: a comparison with continuous infusion. Int J Obstet Anesth. 2005 Oct;14(4):305-9. doi: 10.1016/j.ijoa.2005.05.004.

    PMID: 16154735BACKGROUND
  • Chua SM, Sia AT. Automated intermittent epidural boluses improve analgesia induced by intrathecal fentanyl during labour. Can J Anaesth. 2004 Jun-Jul;51(6):581-5. doi: 10.1007/BF03018402.

    PMID: 15197122BACKGROUND
  • Kaynar AM, Shankar KB. Epidural infusion: continuous or bolus? Anesth Analg. 1999 Aug;89(2):534. doi: 10.1097/00000539-199908000-00063. No abstract available.

    PMID: 10439786BACKGROUND
  • Hogan Q. Distribution of solution in the epidural space: examination by cryomicrotome section. Reg Anesth Pain Med. 2002 Mar-Apr;27(2):150-6. doi: 10.1053/rapm.2002.29748.

    PMID: 11915061BACKGROUND
  • Comparative Obstetric Mobile Epidural Trial (COMET) Study Group UK. Effect of low-dose mobile versus traditional epidural techniques on mode of delivery: a randomised controlled trial. Lancet. 2001 Jul 7;358(9275):19-23. doi: 10.1016/S0140-6736(00)05251-X.

    PMID: 11454372BACKGROUND

MeSH Terms

Conditions

PainLabor Pain

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Limitations and Caveats

A larger study would need to evaluate the secondary outcomes as the current study was underpowered to evaluate the analgesic secondary outcomes.

Results Point of Contact

Title
Paul Fitzgerald
Organization
Northwestern University

Study Officials

  • Feyce Peralta, MD

    Northwestern University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
The participant and outcomes assessor will be blinded to the assigned randomization.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Two group randomized controlled trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 30, 2018

First Posted

June 12, 2018

Study Start

January 21, 2020

Primary Completion

May 31, 2023

Study Completion

June 1, 2023

Last Updated

May 21, 2025

Results First Posted

May 21, 2025

Record last verified: 2025-05

Locations